2024-11-13 - Analysis Report
## Teladoc Health Inc (TDOC) Stock Analysis:

**1. Performance Comparison:**

Teladoc Health Inc (TDOC) is a telehealth company providing virtual healthcare services. 

**TDOC** has a cumulative return of **54.81%**, significantly lagging behind the **S&P 500 (VOO)** with a cumulative return of **176.8%**. This puts **TDOC** at a relative distance of **-121.99**, which corresponds to the **44th percentile** of historical performance compared to the S&P 500. This indicates **TDOC** has underperformed the market significantly. 

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 83.4% | 54.5% | 45.0% | 1.3 | 6.0 |
| 2016-2018  | 175.5% | 46.7% | 143.2% | 1.7 | 8.5 |
| 2017-2019  | 407.4% | 46.7% | 355.7% | 1.8 | 14.4 |
| 2018-2020  | 452.4% | 46.7% | 405.0% | 0.7 | 34.4 |
| 2019-2021  | 90.6% | 55.8% | -9.5% | 0.5 | 15.8 |
| 2020-2022  | -71.6% | 61.0% | -95.2% | 0.8 | 4.1 |
| 2021-2023  | -89.3% | 64.9% | -124.2% | 1.9 | 3.7 |
| 2022-2024  | -89.8% | 45.9% | -120.1% | 1.9 | 1.7 |

The table showcases TDOC's volatile performance, with high CAGR and MDD values in earlier years, followed by significant drops in recent years. The Alpha values indicate TDOC's outperformance against the market in the past, while Beta reveals its high volatility compared to the market. 

**2. Recent Price Movements:**

* Closing Price: **9.7**
* 5-Day Moving Average: **9.54**
* 20-Day Moving Average: **9.21**
* 60-Day Moving Average: **8.53**

The current price of TDOC is slightly above its 5-day moving average, suggesting a potential uptrend. However, it is still below its 20-day and 60-day moving averages, indicating a longer-term downtrend. 

**3. Technical Indicators:**

* **RSI:** 65.27: This suggests the stock is in the overbought territory, potentially indicating a short-term pullback.
* **PPO:** 0.52: This indicates a bullish signal, suggesting a potential uptrend.
* **Delta_Previous_Relative_Divergence:** -0.25 (-): This shows a short-term downtrend in relative divergence, which might indicate the stock is losing momentum compared to the broader market.
* **Expected Return:** 0.0%: This implies that TDOC is expected to perform in line with the S&P 500 in the long term (2 years or more).

**4. Recent Earnings and Outlook:**

| Date       | EPS        | Revenue      |
|------------|-------------|--------------|
| 2024-10-31 | -0.19       | 0.64 B$      |
| 2024-08-01 | -4.92       | 0.64 B$      |
| 2024-04-26 | -0.49       | 0.65 B$      |
| 2023-10-27 | -0.35       | 0.66 B$      |
| 2024-10-31 | -0.35       | 0.66 B$      |

TDOC's recent earnings show a consistent decline in EPS, despite relatively stable revenue. The most recent earnings report for Q3 2024 should be analyzed against analyst estimates to assess performance against expectations.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter       | Revenue      | Profit Margin |
|------------|--------------|---------------|
| 2024-09-30  | $0.64B      | 71.94%        |
| 2024-06-30  | $0.64B      | 70.73%        |
| 2024-03-31  | $0.65B      | 69.89%        |
| 2023-12-31  | $0.66B      | 70.72%        |
| 2023-09-30  | $0.66B      | 71.83%        |

**Capital and Profitability:**

| Quarter       | Equity     | ROE          |
|------------|-------------|--------------|
| 2024-09-30  | $1.51B      | -2.21%       |
| 2024-06-30  | $1.50B      | -55.77%      |
| 2024-03-31  | $2.29B      | -3.58%       |
| 2023-12-31  | $2.33B      | -1.24%       |
| 2023-09-30  | $2.29B      | -2.49%       |

The financial data shows stable revenue, but concerning negative ROE, suggesting a need to analyze the company's capital structure and profitability in detail.

**6. News and Recent Issues:**

* **Recent Earnings News:** Analyze recent earnings announcements (from sources like shacknews.com) to understand the market reaction and analyst sentiments.
* **Recent Market Outlook:** Research recent market outlooks for TDOC, including analyst opinions, growth prospects, and performance highlights. Resources like Finbold.com can be helpful.
* **Key Issues:** Identify any current issues facing the company, such as competitive pressure, regulatory changes, or changing consumer behavior.

**7. Overall Analysis:**

TDOC has significantly underperformed the S&P 500 in recent years, exhibiting high volatility and declining earnings. While the company has a strong profit margin and stable revenue, its negative ROE and recent price action suggest a challenging situation. It is crucial to assess the recent earnings report, market outlook, and potential catalysts for future growth before making any investment decisions. 

**8. English Report:**

This report provides a comprehensive analysis of Teladoc Health Inc (TDOC) based on its performance against the S&P 500, recent price movements, technical indicators, financial information, and news. The analysis shows TDOC's underperformance in recent years and the need for further investigation into its profitability and growth prospects. 

It is important to remember that this analysis is based on the information provided and should not be considered financial advice. You should consult with a qualified financial professional before making any investment decisions.